Yüklüyor......

Molecular landscape and targeted therapy of acute myeloid leukemia

For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous leukemia, which proved that targeted therapy by identifying...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomark Res
Asıl Yazarlar: Gu, Runxia, Yang, Xue, Wei, Hui
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6225571/
https://ncbi.nlm.nih.gov/pubmed/30455953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-018-0146-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!